Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.01
Ask:
2.19
Spread: 0.18 (8.955%)
Market Cap: £44.34m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

AGM Statement

21 Jul 2014 17:46

RNS Number : 9192M
Quintain Estates & Development PLC
21 July 2014
 



21 July 2014

QUINTAIN ESTATES & DEVELOPMENT PLC

RESULTS OF ANNUAL GENERAL MEETING

 

Quintain Estates and Development plc ('Quintain') announces that at the Annual General Meeting held today all the resolutions set out in the Notice of Meeting were passed on a poll and the results are shown below:

 

For*

%

Against

%

Total Votes

 % of issued capital voted

Votes withheld

1.

Adopt 2014 Annual Report

407,124,497

100.00

1,372

0.00

407,125,869

77.38%

65,349

2.

Approve Directors' Remuneration Report

401,092,126

98.77

5,012,906

1.23

406,105,032

77.19%

1,086,186

3.

Approve Remuneration Policy

359,898,140

91.11

35,116,709

8.89

395,014,849

75.08%

12,176,369

4.

Re-elect William Rucker

301,889,443

86.99

45,158,232

13.01

347,047,675

65.96%

55,405,868

5.

Re-elect Chris Bell

406,461,750

99.84

661,965

0.16

407,123,715

77.38%

67,503

6.

Re-elect Charles Cayzer

379,471,463

93.21

27,652,252

6.79

407,123,715

77.38%

67,503

7.

Re-elect Peter Dixon

406,662,554

99.89

461,161

0.11

407,123,715

77.38%

67,503

8.

Re-elect Maxwell James

406,521,253

99.85

602,462

0.15

407,123,715

77.38%

67,503

9.

Re-elect Nigel Kempner

403,474,486

99.10

3,649,229

0.90

407,123,715

77.38%

67,503

10.

Re-elect Ros Kerslake

406,459,121

99.84

663,421

0.16

407,122 542

77.38%

68,676

11.

Re-elect Simon Laffin

406,463,898

99.84

658,837

0.16

407,122,735

77.38%

68,483

12.

Re-elect Richard Stearn

404,634,500

99.39

2,488,235

0.61

407,122,735

77.38%

68,483

13.

Appoint KPMG LLP as auditors

400,941,082

99.83

663,232

0.17

401,604,314

76.33%

5,586,904

14.

Authorise the directors to determine the auditors' remuneration

404,433,067

99.80

804,311

0.20

405,237,378

77.02%

1,953,840

15.

Authorise directors to allot securities

406,199,788

99.77

917,594

0.23

407,117,382

77.38%

73,836

16.

Approve the 2014 Share Incentive Plan

383,700,815

94.25

23,415,227

5.75

407,116,042

77.38%

73,836

17.

Disapply pre-emption rights

406,963,032

99.97

141,750

0.03

407,104,782

77.38%

86,436

18.

Authorise the company to make market purchases of own shares

406,999,404

99.97

113,465

0.03

407,112,869

77.38%

78,349

19.

Authorise general meetings on 14 days' notice

360,093,363

88.45

47,032,506

11.55

407,125,869

77.38%

65,349

* For votes include Chairman's discretion

 

Sandra Odell

Company Secretary

Tel: 020 7495 8968

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMEAKXFALSLEFF
Date   Source Headline
1st Aug 20247:00 amRNSValkor Project Update
10th Jul 20247:00 amRNSMarine Project Update
26th Jun 20247:00 amRNSExtended agreement with BTG Bioliquids for bioMSAR
29th May 20247:00 amRNSRepresentation Agreement Addendum & Warrants Grant
28th May 20247:00 amRNSOCP Commercial Framework Agreement
2nd May 20247:00 amRNSQuadrise-Vertoro JDA to sea-trial bioMSAR Zero
29th Apr 20247:00 amRNSMarine Project Update
19th Apr 20247:00 amRNSValkor Project Update
12th Apr 20244:58 pmRNSResults of Open Offer
22nd Mar 20243:10 pmRNSExtension of Open Offer Closing Date
20th Mar 20241:01 pmRNSInvestor Presentation
19th Mar 20247:00 amRNSPlacing Results, Open Offer & Posting of Circular
18th Mar 20244:55 pmRNSProposed Placing, Subscription and Open Offer
18th Mar 20244:53 pmRNSInterim Results
15th Feb 20247:00 amRNSAgreement with Euthenia & BTG Bioliquids
6th Feb 20247:00 amRNSMarine Project Update
6th Dec 20237:00 amRNSUpdate re bioMSARâ„¢ and bioMSARâ„¢ Zero Development
27th Nov 20235:46 pmRNSResult of AGM
27th Nov 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSMorocco Project Update
9th Nov 20237:00 amRNSPublication of 2023 Sustainability Report
31st Oct 202312:45 pmRNSMorocco Project Update
27th Oct 20234:20 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20239:33 amRNSChange of Nominated Adviser
2nd Oct 20237:30 amRNSDirectorate Change
2nd Oct 20237:00 amRNSFinal Results and Notice of AGM
12th Sep 20237:00 amRNSMorocco Project Update
29th Aug 20237:00 amRNSValkor Project Update
24th Aug 202312:29 pmRNSValkor Update
18th Aug 20233:46 pmRNSMorocco Update
4th Aug 20237:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20234:15 pmRNSDirector/PDMR Shareholding
28th Jul 20234:25 pmRNSDirector/PDMR Shareholding
25th Jul 20233:34 pmRNSResults of Open Offer
7th Jul 202312:00 pmRNSInvestor Presentation
7th Jul 202310:38 amRNSPlacing Results, Open Offer & Posting of Circular
7th Jul 20237:00 amRNSProposed Placing and Open Offer
22nd Jun 20237:00 amRNSMorocco Update
12th Jun 20237:00 amRNSValkor Site License & Supply Agreement
8th Jun 20237:00 amRNSJoint Development Agreement with BTG Bioliquids
26th May 20237:00 amRNSVertoro Joint Development Agreement Update
22nd May 20237:00 amRNSMorocco Update
16th May 20234:29 pmRNSReplacement: Business Update
16th May 20237:00 amRNSBusiness Update
25th Apr 20237:00 amRNSAppointment of Joint Broker
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company
15th Oct 20154:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.